|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
70,932,000 |
Market
Cap: |
2.72(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$15.81 - $52.44 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company focused on changing the paradigm for the treatment of rare genetic diseases of obesity, which are characterized by early-onset, severe obesity and hyperphagia, a pathological and insatiable hunger. Co. is developing IMCIVREE (setmelanotide) as a medicine strategy for a subset of individuals who have severe obesity due to genetic variants that impair the melanocortin-4 receptor pathway, a pathway in the brain that is responsible for regulating hunger, caloric intake and energy expenditure, which consequently affect body weight.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
252,926 |
366,664 |
386,701 |
425,485 |
Total Sell Value |
$10,916,513 |
$14,953,571 |
$15,456,647 |
$16,295,598 |
Total People Sold |
7 |
7 |
7 |
8 |
Total Sell Transactions |
26 |
37 |
41 |
60 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mazabraud Yann |
EVP, Head of International |
|
2024-04-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,375 |
34,870 |
|
- |
|
German Christopher Paul |
Corporate Controller & CAO |
|
2024-04-02 |
4 |
AS |
$41.76 |
$15,368 |
D/D |
(368) |
795 |
|
-4% |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-03-21 |
4 |
AS |
$40.34 |
$735,600 |
D/D |
(18,235) |
30 |
|
-6% |
|
German Christopher Paul |
Corporate Controller & CAO |
|
2024-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,163 |
1,163 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2024-03-20 |
4 |
AS |
$38.22 |
$707,005 |
D/D |
(18,235) |
6,852 |
|
-4% |
|
Meeker David P |
President and CEO |
|
2024-03-19 |
4 |
AS |
$39.22 |
$1,784,275 |
D/D |
(45,494) |
174,605 |
|
-2% |
|
Smith Hunter C |
Chief Financial Officer |
|
2024-03-19 |
4 |
AS |
$39.22 |
$608,498 |
D/D |
(15,515) |
97,939 |
|
-2% |
|
Chien Jennifer |
EVP, Head of North America |
|
2024-03-19 |
4 |
AS |
$39.22 |
$608,498 |
D/D |
(15,515) |
25,087 |
|
-2% |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2024-03-19 |
4 |
AS |
$39.22 |
$608,498 |
D/D |
(15,515) |
30,005 |
|
-2% |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-03-19 |
4 |
AS |
$39.22 |
$608,498 |
D/D |
(15,515) |
18,265 |
|
-2% |
|
Mazabraud Yann |
EVP, Head of International |
|
2024-03-19 |
4 |
AS |
$39.22 |
$627,520 |
D/D |
(16,000) |
24,495 |
|
-2% |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
33,780 |
|
- |
|
Meeker David P |
President and CEO |
|
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
99,000 |
220,099 |
|
- |
|
Chien Jennifer |
EVP, Head of North America |
|
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
40,602 |
|
- |
|
Mazabraud Yann |
EVP, Head of International |
|
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
40,495 |
|
- |
|
Smith Hunter C |
Chief Financial Officer |
|
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
113,454 |
|
- |
|
Cramer Pamela J. |
Chief Human Resources Officer |
|
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
45,520 |
|
- |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-02-14 |
4 |
AS |
$50.01 |
$54,461 |
D/D |
(1,089) |
30 |
|
-24% |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-02-13 |
4 |
AS |
$50.00 |
$93,250 |
D/D |
(1,865) |
1,119 |
|
-22% |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-02-13 |
4 |
AS |
$49.84 |
$23,574 |
D/D |
(473) |
2,984 |
|
-22% |
|
Smith Hunter C |
Chief Financial Officer |
|
2024-02-13 |
4 |
AS |
$49.82 |
$35,322 |
D/D |
(709) |
79,704 |
|
-22% |
|
Mazabraud Yann |
EVP, Head of International |
|
2024-02-13 |
4 |
AS |
$49.84 |
$47,697 |
D/D |
(957) |
6,745 |
|
-22% |
|
Chien Jennifer |
EVP, Head of North America |
|
2024-02-13 |
4 |
AS |
$49.83 |
$30,645 |
D/D |
(615) |
6,852 |
|
-22% |
|
Shulman Joseph |
Chief Technical Officer |
|
2024-02-12 |
4 |
AS |
$51.38 |
$40,642 |
D/D |
(791) |
3,457 |
|
-27% |
|
Smith Hunter C |
Chief Financial Officer |
|
2024-02-12 |
4 |
AS |
$51.38 |
$62,118 |
D/D |
(1,209) |
80,413 |
|
-27% |
|
251 Records found
|
|
Page 1 of 11 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|